Department of Medicine

(iStock)
January 8, 2025

Worldwide experts release clinical recommendations for management of ATM cancer risk 

Researchers established decades ago that ataxia-telangiectasia mutated (ATM) heterozygotes are at an increased risk for cancer, there remains a need to provide clear guidance for clinicians.

Vanderbilt’s 2,000th heart transplant patient, Wes Carter, with his family: wife, Ashley, daughter, Presley (4) and son, Gentry (7).
January 6, 2025

Heart transplant program reaches new landmark

The recipient of the 2,000th transplant was Wes Carter, 37, a real estate agent from Pensacola, Florida, who first noticed an irregular heart rhythm in his mid-20s.

January 3, 2025

AI tested for alerting clinicians of suicide risk at three VUMC clinics

At neurology clinics the system was used to flag 8% of arriving patients as having relatively high risk for suicide attempt in the next 30 days.

December 20, 2024

Vanderbilt Center for Transplant Science announces leadership team 

The center was created earlier this year to save the lives of patients waiting for a transplant and improve outcomes for patients after they receive a transplant.

December 19, 2024

Proteomic signature a key to early detection of fatty liver disease: study

Currently, methods to detect early, obesity-related accumulation of fat in the liver other than a liver biopsy — the surgical removal of liver tissue for microscopic examination — are limited. But there is hope.

December 18, 2024

VUMC part of multisite team investigating genetic markers of anorexia nervosa

With funding from the newly established Sarah Kyle Anorexia Nervosa Research Foundation, the researchers hope to identify biomarkers that will point to novel targets for prevention and treatment.